CJ Cheiljedang Zukünftiges Wachstum

Future Kriterienprüfungen 1/6

CJ Cheiljedang wird ein jährliches Gewinn- und Umsatzwachstum von 18% bzw. 3.9% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich wachsen um 19.9% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 8.7% betragen.

Wichtige Informationen

17.3%

Wachstumsrate der Gewinne

19.3%

EPS-Wachstumsrate

Food Gewinnwachstum	14.9%
Wachstumsrate der Einnahmen	4.0%
Zukünftige Eigenkapitalrendite	8.5%
Analystenabdeckung	Good
Zuletzt aktualisiert	29 Aug 2024

Jüngste Aktualisierungen zum künftigen Wachstum

Recent updates

Why We're Not Concerned About CJ Cheiljedang Corporation's (KRX:097950) Share Price

Mar 01

Robust Earnings May Not Tell The Whole Story For CJ Cheiljedang (KRX:097950)

Mar 25

Shareholders Are Loving CJ Cheiljedang Corporation's (KRX:097950) 0.8% Yield

Mar 18

Is There An Opportunity With CJ Cheiljedang Corporation's (KRX:097950) 46% Undervaluation?

Mar 03

Returns On Capital At CJ Cheiljedang (KRX:097950) Paint An Interesting Picture

Feb 16

Do Institutions Own CJ Cheiljedang Corporation (KRX:097950) Shares?

Feb 01

Does CJ Cheiljedang (KRX:097950) Have A Healthy Balance Sheet?

Jan 17

Are Robust Financials Driving The Recent Rally In CJ Cheiljedang Corporation's (KRX:097950) Stock?

Jan 02

CJ Cheiljedang Corporation (KRX:097950) Is An Attractive Dividend Stock - Here's Why

Dec 15

Are Investors Undervaluing CJ Cheiljedang Corporation (KRX:097950) By 46%?

Nov 27

Gewinn- und Umsatzwachstumsprognosen

KOSE:A097950 - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (KRW Millions)
Datum	Umsatz	Gewinne	Freier Cashflow	Bargeld aus operativen Tätigkeiten	Durchschn. Anz. Analysten
12/31/2026	32,205,469	718,771	1,200,700	2,538,200	11
12/31/2025	30,987,296	651,113	1,112,167	2,383,800	12
12/31/2024	29,767,009	524,225	825,800	2,281,700	11
6/30/2024	29,187,523	471,400	1,298,956	2,358,695	N/A
3/31/2024	29,168,274	439,225	1,393,855	2,550,350	N/A
12/31/2023	29,023,473	353,922	1,167,278	2,444,760	N/A
9/30/2023	29,305,107	275,761	1,247,844	2,671,649	N/A
6/30/2023	29,873,593	292,868	1,121,671	2,664,106	N/A
3/31/2023	30,170,778	403,606	611,166	2,174,722	N/A
12/31/2022	30,079,513	595,930	69,212	1,627,293	N/A
9/30/2022	29,456,255	666,949	-298,469	1,181,591	N/A
6/30/2022	28,298,406	648,965	-264,530	1,096,576	N/A
3/31/2022	27,091,013	646,485	-307,641	969,105	N/A
12/31/2021	26,289,228	612,890	246,278	1,686,409	N/A
9/30/2021	25,492,850	480,377	98,178	1,470,121	N/A
6/30/2021	24,981,231	469,979	245,597	1,592,677	N/A
3/31/2021	24,592,893	407,222	981,109	2,267,146	N/A
12/31/2020	24,245,726	685,582	935,151	2,001,752	N/A
9/30/2020	24,055,576	788,821	1,629,579	2,636,096	N/A
6/30/2020	23,571,220	650,520	1,072,659	2,263,414	N/A
3/31/2020	23,165,651	555,291	356,755	1,817,998	N/A
12/31/2019	22,352,462	152,480	463,368	2,143,096	N/A
9/30/2019	21,313,323	-50,127	-474,424	1,327,047	N/A
6/30/2019	20,400,787	55,971	-865,628	1,029,915	N/A
3/31/2019	19,339,225	798,220	-1,216,291	626,831	N/A
12/31/2018	18,670,060	819,821	-1,300,582	471,425	N/A
9/30/2018	18,039,002	939,612	-1,319,510	512,235	N/A
6/30/2018	17,504,082	1,087,967	-1,068,097	810,882	N/A
3/31/2018	16,959,228	350,666	N/A	1,132,008	N/A
12/31/2017	16,477,174	370,155	N/A	1,180,837	N/A
9/30/2017	15,926,675	359,440	N/A	1,061,646	N/A
6/30/2017	15,195,058	214,093	N/A	686,522	N/A
3/31/2017	14,895,769	235,258	N/A	816,820	N/A
12/31/2016	14,563,257	275,910	N/A	800,142	N/A
9/30/2016	14,095,826	290,360	N/A	740,490	N/A
6/30/2016	13,783,186	210,122	N/A	970,550	N/A
3/31/2016	13,338,599	219,652	N/A	957,333	N/A
12/31/2015	12,924,472	189,260	N/A	1,154,573	N/A
9/30/2015	12,731,328	180,909	N/A	1,131,462	N/A
6/30/2015	12,337,675	158,962	N/A	983,591	N/A
3/31/2015	12,000,155	133,948	N/A	979,592	N/A
12/31/2014	11,701,797	91,957	N/A	688,562	N/A
9/30/2014	11,344,347	50,881	N/A	755,916	N/A
6/30/2014	11,294,940	162,515	N/A	976,255	N/A
3/31/2014	11,220,807	130,813	N/A	400,494	N/A
12/31/2013	10,847,718	116,660	N/A	590,904	N/A
9/30/2013	10,547,748	199,824	N/A	423,334	N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: A097950Das prognostizierte Gewinnwachstum (19.8% pro Jahr) liegt über der Sparquote (2.5%).

Ertrag vs. Markt: A097950Die Erträge des Unternehmens (19.8% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt KR (28.3% pro Jahr).

Hohe Wachstumserträge: A097950Die Erträge des Unternehmens werden voraussichtlich steigen, jedoch nicht deutlich.

Einnahmen vs. Markt: A097950Die Einnahmen des Unternehmens (3.9% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt KR (10.6% pro Jahr).

Hohe Wachstumseinnahmen: A097950Die Einnahmen des Unternehmens (3.9% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: A097950Die Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich niedrig sein (8.7 %).

CJ Cheiljedang Zukünftiges Wachstum

Future Kriterienprüfungen 1/6

Wichtige Informationen

Jüngste Aktualisierungen zum künftigen Wachstum

Consensus EPS estimates fall by 12%

Consensus EPS estimates increase by 18%

Consensus EPS estimates fall by 23%

Consensus EPS estimates increase by 19%, revenue downgraded

Consensus EPS estimates fall by 22%

Price target decreased to ₩534,375

Recent updates

Upcoming dividend of ₩1,000 per share

Does CJ Cheiljedang (KRX:097950) Have A Healthy Balance Sheet?

CJ Cheiljedang Corporation to Report First Half, 2024 Results on Aug 13, 2024

CJ Cheiljedang Corporation's (KRX:097950) Price In Tune With Earnings

CJ Cheiljedang (KRX:097950) Use Of Debt Could Be Considered Risky

CJ Cheiljedang Corporation to Report Q1, 2024 Results on May 14, 2024

Full year 2023 earnings released: EPS: ₩24,081 (vs ₩37,188 in FY 2022)

Why We're Not Concerned About CJ Cheiljedang Corporation's (KRX:097950) Share Price

Consensus EPS estimates fall by 12%

CJ Cheiljedang Corporation to Report Fiscal Year 2023 Results on Feb 13, 2024

Upcoming dividend of ₩2,500 per share at 1.7% yield

Consensus EPS estimates increase by 18%

Consensus EPS estimates fall by 23%

CJ CheilJedang's CJ Foods Appoints Stephan Czypionka as Global Chief Marketing Officer

CJ Cheiljedang Corporation to Report Q3, 2023 Results on Nov 13, 2023

CJ CheilJedang's Business Unit CJ Foods Appoints Gregory Yep as New CTO of Global Food R&D

Upcoming dividend of ₩1,000 per share at 1.8% yield

Second quarter 2023 earnings released: EPS: ₩4,114 (vs ₩11,030 in 2Q 2022)

Consensus EPS estimates increase by 19%, revenue downgraded

An unknown buyer acquired 60% stake in Sichuan Jixiangju Food Co., Ltd. from CJ Cheiljedang Corporation for KRW 300 billion.

CJ Cheiljedang Corporation to Report Q2, 2023 Results on Aug 07, 2023

Upcoming dividend of ₩1,000 per share at 2.0% yield

Full year 2022 earnings: EPS misses analyst expectations

Upcoming dividend of ₩1,000 per share at 1.7% yield

Consensus EPS estimates fall by 22%

Insufficient new directors

CJ Cheiljedang Corporation to Report Q3, 2022 Results on Nov 14, 2022

Second quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

First quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

CJ Cheiljedang Reportedly Puts CJ Selecta Up for Sale

Insufficient new directors

Price target decreased to ₩534,375

CJ Cheiljedang Corporation to Report Q4, 2021 Results on Feb 14, 2022

Upcoming dividend of ₩4,000 per share

Third quarter 2021 earnings released: EPS ₩13,181 (vs ₩11,805 in 3Q 2020)

Second quarter 2021 earnings released: EPS ₩16,317 (vs ₩10,373 in 2Q 2020)

CJ Cheiljedang Corporation (KOSE:A097950) signed a stock purchase contract to acquire 15.99% stake in ChunLab, Inc. (KOSDAQ:A311690) from Jong-sik Cheon and Shanghai ZJ Bio-Tech Co., Ltd. (SHSE:688317) for KRW 25 billion.

CJ Cheiljedang Corporation (KOSE:A097950) acquired additional 19% stake in CJ Foods America Corp. from Bain Capital Credit, LP for $440 million.

Robust Earnings May Not Tell The Whole Story For CJ Cheiljedang (KRX:097950)

Full year 2020 earnings released: EPS ₩42,783 (vs ₩9,516 in FY 2019)

Shareholders Are Loving CJ Cheiljedang Corporation's (KRX:097950) 0.8% Yield

CJ Cheiljedang Corporation, Annual General Meeting, Mar 26, 2021

Is There An Opportunity With CJ Cheiljedang Corporation's (KRX:097950) 46% Undervaluation?

Returns On Capital At CJ Cheiljedang (KRX:097950) Paint An Interesting Picture

Do Institutions Own CJ Cheiljedang Corporation (KRX:097950) Shares?

New 90-day high: ₩471,000

CJ Cheiljedang Corporation to Report Q4, 2020 Results on Feb 08, 2021

Does CJ Cheiljedang (KRX:097950) Have A Healthy Balance Sheet?

New 90-day high: ₩414,500

Are Robust Financials Driving The Recent Rally In CJ Cheiljedang Corporation's (KRX:097950) Stock?

Upcoming Dividend of ₩3,500 Per Share

CJ Cheiljedang Corporation (KRX:097950) Is An Attractive Dividend Stock - Here's Why

New 90-day low: ₩357,000

Are Investors Undervaluing CJ Cheiljedang Corporation (KRX:097950) By 46%?

CJ CheilJedang Appoints Dimitrios Smyrnios as Executive Chairman of CJCJ Food, Americas

CJ Cheiljedang Corporation to Report Q3, 2020 Results on Nov 10, 2020

New 90-day low: ₩363,000

CJ Cheiljedang Corporation to Report Q2, 2020 Final Results on Aug 11, 2020

Price target raised to ₩479,389

New 90-day high - ₩412,000

Gewinn- und Umsatzwachstumsprognosen

Analystenprognosen zum zukünftigen Wachstum

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Wachstumsunternehmen entdecken